USFDA approved Novartis’s injectable drug, Cosentyx for plaque psoriasis
Secukinumab is a human monoclonal antibody designed for the treatments of uveitis, rheumatoid arthritis, ankylosing spondylitis, and psoriasis. It targets memberĀ A from... Read More